Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...
Associate Professor, Director of the Microscopy and Cytometry Core Facility at Amsterdam UMC and Co-Director of the Immune Monitoring Unit at the Amsterdam UMC Immunotherapy Center Multiplexed ...
(RTTNews) - Akoya Biosciences, Inc. (AKYA), Thursday announced the launch of a new multiplex immunofluorescence or mIF assay to advance antibody-drug conjugate or ADC development in breast cancer, ...
Hamamatsu Photonics of Japan and Massachusetts-based Vizgen have announced a strategic partnership intended to speed up research laboratory workflows. The collaboration will in particular aim to ...
Please provide your email address to receive an email when new articles are posted on . A novel assay may help direct antibody-drug conjugate therapy through measurements of HER2 and TROP2. Most ...
The immunofluorescence image details the morphology and cell composition of a femur from a middle-aged mouse. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results